Drug Development

Altaris Takes Simulations Plus Private for $375M: What Healthcare PE Is Betting On

TL;DR: On June 16, 2026, Altaris Capital Partners announced a $375 million all-cash deal to take Simulations Plus (Nasdaq: SLP) private at $18.50 per share, a 26% premium to the 60-day volume-weighted